Search results for "Highlights"
High-sensitivity C-reactive protein level predicted mortality risk in recent-onset type 2 diabetes
While high-sensitivity C-reactive protein was a good predictor of mortality, C-peptide levels were more closely associated with cardiovascular events, and having high levels of both was associated with increased risk of either outcome, a prospective study in Denmark found.
https://diabetes.acponline.org/archives/2023/04/14/1.htm
14 Apr 2023
Overnight glucose associated with next-day functioning in adults with type 1 diabetes
More variation in overnight glucose levels and time spent above and below glucose targets were associated with adverse changes in measures of next-day function, including attention, sedentary time, and engagement in demanding activities, a study found.
https://diabetes.acponline.org/archives/2023/03/10/2.htm
10 Mar 2023
Vitamin D may reduce risk of progression to diabetes from prediabetes
In adults with prediabetes, high-dose vitamin D was associated with a 12% to 15% reduced risk for diabetes compared with placebo, a systematic review and meta-analysis found, but an editorial cautioned about the uncertain risk of adverse effects.
https://diabetes.acponline.org/archives/2023/02/10/3.htm
10 Feb 2023
Insulin prices drop, may spur long-term trend
A major manufacturer announced a cut in the prices of its insulins and instituted a $35 out-of-pocket monthly cap for commercially insured patients.
https://diabetes.acponline.org/archives/2023/03/10/1.htm
10 Mar 2023
Metformin during pregnancy not associated with adiposity in children
A follow-up study of a randomized trial of women with type 2 diabetes during pregnancy found that scores for body mass index were similar up to age 24 months in children who were and were not exposed to metformin in utero.
https://diabetes.acponline.org/archives/2023/02/10/2.htm
10 Feb 2023
Fiber-enriched formula linked to improved health-related quality of life, HbA1c in type 2 diabetes
Participants who consumed prebiotic fiber-enriched nutritional shakes had improved measures of health-related quality of life and reduced HbA1c level at 12 weeks compared to those who consumed placebo shakes, an industry-funded trial found.
https://diabetes.acponline.org/archives/2023/01/13/3.htm
13 Jan 2023
Spotlight on diabetes drug class comparisons
A large trial compared insulin, a sulfonylurea, a glucagon-like peptide-1 (GLP-1) receptor agonist, and a dipeptidyl peptidase-4 inhibitor as second-line therapy, while a modeling study considered GLP-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors as first-line agents.
https://diabetes.acponline.org/archives/2022/10/14/5.htm
14 Oct 2022
HbA1c at diagnosis may predict metformin failure, study finds
A model that included baseline HbA1c level, age, sex, and race/ethnicity had high discrimination for predicting failure risk, with the strongest association seen for HbA1c.
https://diabetes.acponline.org/archives/2023/01/13/2.htm
13 Jan 2023
SGLT-2 inhibitors reduce cardiac events, mortality compared to DPP-4 inhibitors
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors were associated with lower risk of cardiovascular events compared to dipeptidyl peptidase-4 (DPP-4) inhibitors but higher risk of genital infections and diabetic ketoacidosis, a retrospective study found.
https://diabetes.acponline.org/archives/2023/02/10/1.htm
10 Feb 2023
Diabetes and prior CVD may no longer carry equivalent cardiovascular risk
In a population-based Canadian study, the magnitude of the association between diabetes and risk of cardiovascular events decreased while that between cardiovascular disease (CVD) and such events remained stable.
https://diabetes.acponline.org/archives/2022/11/11/3.htm
11 Nov 2022